Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ke Zu

2PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Sep 11, 2023
Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settings.

Ke Zu, Ashwini Arunachalam, Andriana Hohlbauch

|Sep 05, 2023
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.

Britta Höchsmann, Regis Peffault de Latour, Anita Hill

Pageof 1

Frequent Collaborators

1 joint publications

Britta Höchsmann

1 joint publications

Regis Peffault de Latour

1 joint publications

Anita Hill

1 joint publications

Alexander Röth

1 joint publications

Timothy Devos

1 joint publications

Christopher J Patriquin

1 joint publications

Wen-Chien Chou

1 joint publications

Chuntao Wu

1 joint publications

Jong Wook Lee

1 joint publications

Michelle Silver

Frequent Collaborators

1 joint publications

Britta Höchsmann

1 joint publications

Regis Peffault de Latour

1 joint publications

Anita Hill

1 joint publications

Alexander Röth

Top Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

10.6K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on : May 24, 2020

9.0K
See more related videos

Top Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

10.6K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on : May 24, 2020

9.0K
See more related videos